Latest Insider Transactions at Eastman Chemical CO (EMN)
This section provides a real-time view of insider transactions for Eastman Chemical CO (EMN). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of EASTMAN CHEMICAL CO to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of EASTMAN CHEMICAL CO's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 18
2025
|
Brian Travis Smith EVP, AFP, Mfg., WWEC & HSE |
SELL
Payment of exercise price or tax liability
|
Direct |
1,233
-7.6%
|
$126,999
$103.47 P/Share
|
|
Feb 18
2025
|
Brian Travis Smith EVP, AFP, Mfg., WWEC & HSE |
BUY
Grant, award, or other acquisition
|
Direct |
4,193
+20.55%
|
-
|
|
Feb 18
2025
|
Christopher Moore Killian SVP, CTO & Sust. Ofc, |
SELL
Payment of exercise price or tax liability
|
Direct |
3,210
-13.24%
|
$330,630
$103.47 P/Share
|
|
Feb 18
2025
|
Christopher Moore Killian SVP, CTO & Sust. Ofc, |
BUY
Grant, award, or other acquisition
|
Direct |
11,767
+32.67%
|
-
|
|
Feb 18
2025
|
William Thomas Mc Lain Jr. EVP, CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
6,167
-11.01%
|
$635,201
$103.47 P/Share
|
|
Feb 18
2025
|
William Thomas Mc Lain Jr. EVP, CFO |
BUY
Grant, award, or other acquisition
|
Direct |
19,331
+25.65%
|
-
|
|
Feb 18
2025
|
Michelle H Caveness SVP & Chf. Mfg. Ofc. |
SELL
Payment of exercise price or tax liability
|
Direct |
440
-27.38%
|
$45,320
$103.47 P/Share
|
|
Feb 18
2025
|
Michelle H Caveness SVP & Chf. Mfg. Ofc. |
BUY
Grant, award, or other acquisition
|
Direct |
1,607
+50.0%
|
-
|
|
Feb 18
2025
|
Mark J Costa CEO & Board Chair |
SELL
Payment of exercise price or tax liability
|
Direct |
30,638
-6.42%
|
$3,155,714
$103.47 P/Share
|
|
Feb 18
2025
|
Mark J Costa CEO & Board Chair |
BUY
Grant, award, or other acquisition
|
Direct |
81,525
+14.59%
|
-
|
|
Feb 18
2025
|
Adrian James Holt SVP, Chf HR Ofcr |
SELL
Payment of exercise price or tax liability
|
Direct |
697
-25.49%
|
$71,791
$103.47 P/Share
|
|
Feb 18
2025
|
Adrian James Holt SVP, Chf HR Ofcr |
BUY
Grant, award, or other acquisition
|
Direct |
2,734
+50.0%
|
-
|
|
Feb 18
2025
|
Stephen Glenn Crawford EVP-Methan. Ops & WWEC Transf. |
SELL
Payment of exercise price or tax liability
|
Direct |
5,185
-8.09%
|
$534,055
$103.47 P/Share
|
|
Feb 18
2025
|
Stephen Glenn Crawford EVP-Methan. Ops & WWEC Transf. |
BUY
Grant, award, or other acquisition
|
Direct |
16,810
+20.78%
|
-
|
|
Feb 18
2025
|
Brad A Lich EVP & CCO |
SELL
Payment of exercise price or tax liability
|
Direct |
6,167
-7.0%
|
$635,201
$103.47 P/Share
|
|
Feb 18
2025
|
Brad A Lich EVP & CCO |
BUY
Grant, award, or other acquisition
|
Direct |
19,331
+17.99%
|
-
|
|
Feb 18
2025
|
Michelle Renee Stewart Controller & CAO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,252
-20.14%
|
$128,956
$103.47 P/Share
|
|
Feb 18
2025
|
Michelle Renee Stewart Controller & CAO |
BUY
Grant, award, or other acquisition
|
Direct |
3,993
+39.12%
|
-
|
|
Feb 18
2025
|
Julie A. Mc Alindon SVP, Regions & Chf SupChn Ofcr |
SELL
Payment of exercise price or tax liability
|
Direct |
2,077
-16.22%
|
$213,931
$103.47 P/Share
|
|
Feb 18
2025
|
Julie A. Mc Alindon SVP, Regions & Chf SupChn Ofcr |
BUY
Grant, award, or other acquisition
|
Direct |
8,405
+39.62%
|
-
|
|
Dec 03
2024
|
Adrian James Holt SVP, Chf HR Ofcr |
SELL
Open market or private sale
|
Direct |
3,683
-100.0%
|
$383,032
$104.88 P/Share
|
|
Dec 02
2024
|
Adrian James Holt SVP, Chf HR Ofcr |
SELL
Payment of exercise price or tax liability
|
Direct |
1,186
-24.36%
|
$123,344
$104.27 P/Share
|
|
Dec 02
2024
|
Adrian James Holt SVP, Chf HR Ofcr |
BUY
Exercise of conversion of derivative security
|
Direct |
4,869
+50.0%
|
-
|
|
Dec 02
2024
|
Brad A Lich EVP & CCO |
SELL
Open market or private sale
|
Direct |
36,277
-34.53%
|
$3,772,808
$104.06 P/Share
|
|
Dec 02
2024
|
Brad A Lich EVP & CCO |
BUY
Exercise of conversion of derivative security
|
Direct |
36,277
+25.67%
|
$2,358,005
$65.16 P/Share
|
|
Nov 29
2024
|
Mark J Costa CEO & Board Chair |
SELL
Open market or private sale
|
Direct |
18,278
-4.42%
|
$1,919,190
$105.0 P/Share
|
|
Nov 29
2024
|
Mark J Costa CEO & Board Chair |
BUY
Exercise of conversion of derivative security
|
Direct |
18,278
+4.23%
|
$1,188,070
$65.16 P/Share
|
|
Nov 27
2024
|
Brad A Lich EVP & CCO |
SELL
Open market or private sale
|
Direct |
100
-0.15%
|
$10,500
$105.0 P/Share
|
|
Nov 27
2024
|
Brad A Lich EVP & CCO |
BUY
Exercise of conversion of derivative security
|
Direct |
100
+0.14%
|
$6,500
$65.16 P/Share
|
|
Nov 27
2024
|
Stephen Glenn Crawford EVP-Methan. Ops & WWEC Transf. |
SELL
Open market or private sale
|
Direct |
9,695
-17.01%
|
$1,027,670
$106.0 P/Share
|
|
Nov 27
2024
|
Stephen Glenn Crawford EVP-Methan. Ops & WWEC Transf. |
BUY
Exercise of conversion of derivative security
|
Direct |
9,695
+14.54%
|
$630,175
$65.16 P/Share
|
|
Nov 26
2024
|
Stephen Glenn Crawford EVP-Methan. Ops & WWEC Transf. |
SELL
Open market or private sale
|
Direct |
10,504
-9.13%
|
$1,102,920
$105.03 P/Share
|
|
Nov 26
2024
|
Stephen Glenn Crawford EVP-Methan. Ops & WWEC Transf. |
BUY
Exercise of conversion of derivative security
|
Direct |
10,504
+15.38%
|
$777,296
$74.46 P/Share
|
|
Nov 26
2024
|
Mark J Costa CEO & Board Chair |
SELL
Open market or private sale
|
Direct |
89,732
-9.33%
|
$9,421,860
$105.32 P/Share
|
|
Nov 26
2024
|
Mark J Costa CEO & Board Chair |
BUY
Exercise of conversion of derivative security
|
Direct |
89,732
+7.94%
|
$5,832,580
$65.16 P/Share
|
|
Nov 26
2024
|
Julie A. Mc Alindon SVP, Regions & Chf SupChn Ofcr |
SELL
Open market or private sale
|
Direct |
4,456
-50.3%
|
$467,880
$105.84 P/Share
|
|
Nov 26
2024
|
Julie A. Mc Alindon SVP, Regions & Chf SupChn Ofcr |
BUY
Exercise of conversion of derivative security
|
Direct |
4,456
+33.47%
|
$271,816
$61.51 P/Share
|
|
Nov 06
2024
|
Christopher Moore Killian SVP, CTO & Sust. Ofc, |
SELL
Open market or private sale
|
Direct |
3,061
-19.84%
|
$321,405
$105.0 P/Share
|
|
Jun 03
2024
|
Adrian James Holt SVP, Chf HR Ofcr |
SELL
Open market or private sale
|
Direct |
1,975
-100.0%
|
$195,525
$99.22 P/Share
|
|
Jun 03
2024
|
Adrian James Holt SVP, Chf HR Ofcr |
BUY
Exercise of conversion of derivative security
|
Direct |
1,975
+50.0%
|
$152,075
$77.75 P/Share
|
|
May 15
2024
|
Brad A Lich EVP & CCO |
SELL
Open market or private sale
|
Direct |
23,028
-25.08%
|
$2,302,800
$100.51 P/Share
|
|
May 15
2024
|
Brad A Lich EVP & CCO |
BUY
Exercise of conversion of derivative security
|
Direct |
23,028
+20.05%
|
$1,704,072
$74.46 P/Share
|
|
May 14
2024
|
David W Raisbeck Director |
SELL
Open market or private sale
|
Direct |
13,500
-31.5%
|
$1,350,000
$100.5 P/Share
|
|
May 10
2024
|
Adrian James Holt SVP, Chf HR Ofcr |
SELL
Open market or private sale
|
Direct |
3,662
-100.0%
|
$369,862
$101.26 P/Share
|
|
May 10
2024
|
Adrian James Holt SVP, Chf HR Ofcr |
BUY
Exercise of conversion of derivative security
|
Direct |
3,662
+50.0%
|
$303,946
$83.26 P/Share
|
|
May 07
2024
|
Mark J Costa CEO & Board Chair |
SELL
Open market or private sale
|
Direct |
102,390
-20.56%
|
$10,239,000
$100.78 P/Share
|
|
May 07
2024
|
Mark J Costa CEO & Board Chair |
BUY
Exercise of conversion of derivative security
|
Direct |
102,390
+17.05%
|
$7,576,860
$74.46 P/Share
|
|
May 02
2024
|
Julie Fasone Holder Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,252
+7.94%
|
-
|
|
May 02
2024
|
Renee J Hornbaker Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,252
+5.39%
|
-
|
|
May 02
2024
|
James J /Ky Obrien Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,252
+24.77%
|
-
|